Effector Therapeutics Inc (EFTR)

NASDAQ
0.401
+0.011(+2.82%)
  • Volume:
    5,931
  • Day's Range:
    0.400 - 0.413
  • 52 wk Range:
    0.380 - 9.540

EFTR Overview

Prev. Close
0.394
Day's Range
0.4-0.413
Revenue
3.19M
Open
0.413
52 wk Range
0.38-9.54
EPS
0.138
Volume
5,931
Market Cap
17.3M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
109,214
P/E Ratio
4.76
Beta
1.2
1-Year Change
-94.38%
Shares Outstanding
41,893,140
Next Earnings Date
Mar 15, 2023
What is your sentiment on Effector Therapeutics?
or
Vote to see community's results!

Effector Therapeutics Inc News

Effector Therapeutics Inc Company Profile

Effector Therapeutics Inc Company Profile

Employees
12

eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer. The company is also developing Zotatifin, a small molecule designed to inhibit eukaryotic initiation factor 4A (eIF4E), which is in phase 2clinical trial to treat patients with solid tumors. It has a collaboration agreement with Pfizer Inc. to develop inhibitors of eIF4E. eFFECTOR Therapeutics, Inc. was founded in 2012 and is headquartered in Solana Beach, California.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellStrong SellStrong Sell
Technical IndicatorsBuyBuyStrong SellStrong SellStrong Sell
SummaryNeutralNeutralStrong SellStrong SellStrong Sell
  • Whats the expecting price
    0
    • Why is this up so much? Merger news?
      0
      • They already f cked people who bought above 40 50 lol I would stay away from this
        1
        • Trying to buy since 20
          0
          • Dont buy anymore
            0
        • Why i cant buy this stock
          0
          • Amazing
            0